Contact
✓ Last verified: February 25, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Newport News’s dedicated interventional psychiatry clinic — offering Spravato alongside NeuroStar TMS within North America’s largest TMS network, with free consultations and insurance-covered treatment.
| Review Scores | Part of North America’s largest TMS/Spravato network with 100+ clinics; dedicated Newport News center |
| Location | Newport News, VA |
| Address | 825 Diligence Drive, Suite 226, Newport News, VA 23606 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine) Nasal Spray, NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder with Suicidal Ideation |
| Cost | Contact for pricing; most major insurance plans accepted |
| Insurance | Most major insurance plans accepted |
| Clinical Lead | Licensed mental health provider team — Greenbrook multi-state interventional psychiatry network |
HealingMaps Take: Greenbrook TMS’s Newport News location fills a critical gap on the Peninsula side of Hampton Roads. With most Hampton Roads interventional psychiatry concentrated in Norfolk and Virginia Beach (South side), patients in Newport News, Hampton, Williamsburg, and the Peninsula have historically faced long drives to access Spravato or TMS. Greenbrook’s dedicated Newport News center at 825 Diligence Drive serves this underserved corridor with both FDA-approved interventional options — TMS (NeuroStar) and Spravato — under one clinical roof. Being part of Greenbrook’s multi-state network (100+ clinics across North America) brings operational sophistication to insurance navigation, REMS compliance, and treatment scheduling that single-location practices often struggle with. The free consultation model is also patient-friendly: instead of being charged for an initial evaluation that may or may not lead to treatment, patients can meet with a coordinator and licensed mental health provider at no cost. TMS sessions at just 19 minutes each are unusually short, minimizing time off work during a typical 30-36 session treatment course. For Peninsula patients with treatment-resistant depression who need Spravato or TMS within their insurance network, Greenbrook Newport News is the default Peninsula-side answer.
Market Position: Greenbrook TMS & Spravato is a Spravato-certified clinic in the News metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Is Greenbrook TMS & Spravato Right for You?
✓ Choose Greenbrook TMS & Spravato if:
- You have commercial insurance and a documented treatment-resistant depression diagnosis (Spravato pathway)
✗ Look elsewhere if:
- You’re seeking cash-pay IV ketamine instead of insurance-billed Spravato
- You want ketamine-assisted psychotherapy (KAP) with integrated talk therapy
- You need same-week appointments — Spravato prior authorization typically takes 1–3 weeks
Greenbrook TMS & Spravato Ketamine Cost Calculator
How Much Will Ketamine Therapy Cost?
Estimate your out-of-pocket range based on patient-reported pricing and HealingMaps proprietary clinic data.
Estimated per session
$417–$715
Range: $357–$1,192/session
Estimated total program
$2,502–$4,290
Range: $2,145–$7,150/6-session series
Select a treatment type to see pricing context.
Ketamine Protocols Compared — What’s Offered at Greenbrook TMS & Spravato
Industry pricing reference. Greenbrook TMS & Spravato has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
What to Expect at Your First Greenbrook TMS & Spravato Appointment
- Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (855) 940-4867 to schedule.
- Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Greenbrook TMS & Spravato clinical team.
- First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at 825 Diligence Drive, Suite 226, Newport News, VA 23606. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
- Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.
What to Ask on Your Greenbrook TMS & Spravato Consult Call
- How long has the Greenbrook TMS & Spravato clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
- How long does Greenbrook TMS & Spravato’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
- What does Greenbrook TMS & Spravato recommend for patients who don’t respond to the standard 6-session acute series?
Patient Questions about Greenbrook TMS & Spravato
This 2-question summary is matched to the protocols and conditions Greenbrook TMS & Spravato treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Does Greenbrook TMS & Spravato offer Spravato (esketamine)?
Yes — Greenbrook TMS & Spravato offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Is Greenbrook TMS & Spravato suited for treatment-resistant depression?
Greenbrook TMS & Spravato treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Location
Add Review
Healing Maps Editorial Staff
View all posts by Healing Maps Editorial StaffThe Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.
Leave a Reply